
Opinion|Videos|September 15, 2023
Patient Scenario: A 65-Year-Old Man with HER2+ mCRC
Daniel Walden, MD, presents the scenario of a 65-year-old man diagnosed with HER2+ metastatic colorectal cancer to the expert panel for discussion.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
3
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
4
What Does an End-of-Life Doula Do for Patients With Cancer?
5




























































